GAMMAGARD Liquid ERC

Product NDC
0944-2705
Requested package NDC
0944-2705-50
11-digit product format
009442705
Labeler code
0944
Product ID
0944-2705_2332ff1f-1311-4aaa-9d76-9a011b3f7956
Type
PLASMA DERIVATIVE
Nonproprietary name
Immune Globulin Infusion (Human)
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Labeler
Takeda Pharmaceuticals America, Inc.
Application
BLA125105
Marketing category
BLA
Marketing start
2025-07-14
Substance
HUMAN IMMUNOGLOBULIN G
Active strength
100 mg/mL
Pharmacologic classes
Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
GAMMAGARD Liquid ERC
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HUMAN IMMUNOGLOBULIN G100 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
66Y330CJHSInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1809414Internal RxNorm lookup
1809421Internal RxNorm lookup
2733845Internal RxNorm lookup
2733847Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1341fd31-0754-47f0-a4d6-7255056b6541Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0944-2705-01GAMMAGARD Liquid ERC100 mL in 1 VIAL, GLASSINJECTION, SOLUTION1002
0944-2705-05GAMMAGARD Liquid ERC50 mL in 1 VIAL, GLASSINJECTION, SOLUTION502
0944-2705-10GAMMAGARD Liquid ERC1 in 1 CARTONINJECTION, SOLUTION12
0944-2705-50GAMMAGARD Liquid ERC1 in 1 CARTONINJECTION, SOLUTION12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0944-2705-01ML - Milliliter0944-27052403e9f7-0713-4629-bd51-a369088b63f312026-02-05
0944-2705-05ML - Milliliter0944-2705e51d96de-7f1e-49c2-bafe-96275aee375212026-02-05
0944-2705-10ML - Milliliter0944-270583beec54-eb27-4517-863d-087112d6885912026-02-05
0944-2705-50ML - Milliliter0944-2705b4397ffd-e0fb-4d4b-9251-cd50b1d7eeb012026-02-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GAMMAGARD LiquidIMMUNE GLOBULIN INFUSION (HUMAN)Takeda Pharmaceuticals America, Inc.9d42adca-0dd7-4df7-864d-5a7feee521302025-12-10Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA125105
GAMMAGARD Liquid ERCIMMUNE GLOBULIN INFUSION (HUMAN)Takeda Pharmaceuticals America, Inc.1341fd31-0754-47f0-a4d6-7255056b65412025-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA125105
ndc (package): 0944-2705-50
ndc (product): 0944-2705
ndc11 (package): 00944270550

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125105Gammagard LiquidImmune Globulin Infusion (Human)351(a)Rx2026-10-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2733847GAMMAGARD ERC 10 % in 100 ML InjectionPSN1341fd31-0754-47f0-a4d6-7255056b65412
2733845GAMMAGARD ERC 10 % in 50 ML InjectionPSN1341fd31-0754-47f0-a4d6-7255056b65412
1809421immunoglobulin G, human 10 % in 100 ML InjectionPSN1341fd31-0754-47f0-a4d6-7255056b65412
1809414immunoglobulin G, human 10 % in 50 ML InjectionPSN1341fd31-0754-47f0-a4d6-7255056b65412
2733847100 ML immunoglobulin G, human 100 MG/ML Injection [Gammagard ERC]SBD1341fd31-0754-47f0-a4d6-7255056b65412
273384550 ML immunoglobulin G, human 100 MG/ML Injection [Gammagard ERC]SBD1341fd31-0754-47f0-a4d6-7255056b65412
1809421100 ML immunoglobulin G, human 100 MG/ML InjectionSCD1341fd31-0754-47f0-a4d6-7255056b65412
180941450 ML immunoglobulin G, human 100 MG/ML InjectionSCD1341fd31-0754-47f0-a4d6-7255056b65412
2733847100 ML Gammagard ERC 100 MG/ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
273384550 ML Gammagard ERC 100 MG/ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
2733847Gammagard ERC 10 % per 100 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
2733845Gammagard ERC 10 % per 50 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
2733847Gammagard ERC 10 GM per 100 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
2733845Gammagard ERC 5 GM per 50 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
1809421immunoglobulin G, human 10 % per 100 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
1809414immunoglobulin G, human 10 % per 50 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
1809421immunoglobulin G, human 10 GM per 100 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412
1809414immunoglobulin G, human 5 GM per 50 ML InjectionSY1341fd31-0754-47f0-a4d6-7255056b65412

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0944-2705-50009442705501 VIAL, GLASS in 1 CARTON (0944-2705-50) / 50 mL in 1 VIAL, GLASS (0944-2705-05) 2025-07-14NoNoCurrent